Andaleb Kholmukhamedov/LinkedIn
Oct 4, 2025, 12:38
Andaleb Kholmukhamedov: Anticoagulation Management: Current Landscape And Future Trends
Andaleb Kholmukhamedov, Head of Hemostasis Assay Development at Werfen North America, posted on LinkedIn:
”Latest publication in the MDPI Journal of Clinical Medicine’s Special Issue on Advances in Thrombosis and Haemostasis
Our paper provides a comprehensive review of the current and future landscape of Anticoagulation Therapy – a critical field balancing life-saving clot prevention with bleeding risk.”
Read the full article here.
Title: Anticoagulation Management: Current Landscape and Future Trends
Authors: Andaleb Kholmukhamedov, David Subbotin, Anna Gorin, Ruslan Ilyassov
Stay updated with Hemostasis Today.
Andaleb Kholmukhamedov
Anna Gorin
Anticoagulation
Anticoagulation Management
Anticoagulation Therapy
Bleeding Risk
Blood Clot
David Subbotin
Health
Hematology
Hemostais
Hemostais Today
MDPI Journal
Medicine
Ruslan Ilyassov
San Diego State University
Scripps Memorial Hospital
thrombosis
University of California Los Angeles
Versiti Blood Research Institute
Werfen North America
-
Apr 5, 2026, 19:00Kausik Ray: Comparing Lipid Management in France vs. Rest of Europe for High Cardiovascular Risk Patients
-
Apr 5, 2026, 18:22Omar Adwan: Systematic Approach to Blood Smear Examination
-
Apr 5, 2026, 18:05Heghine Khachatryan: Rethinking Hemostatic Targets in Pregnancy for von Willebrand Disease
-
Apr 5, 2026, 17:45Matthew Walls: Recognising CAD PRS as a New ‘Risk Enhancing Factor’ in the 2026 ACC/AHA Guidelines
-
Apr 5, 2026, 17:44Philip A. Chan: Occasional Heavy Drinking Leads to 3 Times Higher Liver Fibrosis Risk in MASLD
-
Apr 5, 2026, 17:42Josu de la Fuente: Real World Data Shows Significant Risk of Subsequent HCT in SCD and Thalassemia
-
Apr 5, 2026, 17:41Gevorg Yaghjyan: Attending an AI Conference on AI in Clinical Medicine, Research and Education
-
Apr 5, 2026, 17:41Ifeanyichukwu Ifechidere: The Mastermind of Clotting – A Thrombin Story
-
Apr 5, 2026, 17:38Thomas Ichim: Making iPSC Cells from Menstrual Blood Stem Cells